Sean Wieland
Stock Analyst at Piper Sandler
(1.18)
# 3,250
Out of 4,583 analysts
26
Total ratings
45%
Success rate
1.68%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $43.42 | -10.18% | 8 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $9.92 | +1,109.68% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $16.92 | -64.54% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $40.63 | +8.29% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $244.62 | -5.57% | 4 | Feb 18, 2022 | |
| PRVA Privia Health Group | Initiates: Overweight | $40 | $19.44 | +105.76% | 1 | May 24, 2021 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $9.18 | +3,069.93% | 5 | Feb 25, 2021 | |
| ACCD Accolade | Initiates: Overweight | n/a | $4.19 | - | 1 | Jul 27, 2020 |
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $43.42
Upside: -10.18%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $9.92
Upside: +1,109.68%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $16.92
Upside: -64.54%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $40.63
Upside: +8.29%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $244.62
Upside: -5.57%
Privia Health Group
May 24, 2021
Initiates: Overweight
Price Target: $40
Current: $19.44
Upside: +105.76%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $9.18
Upside: +3,069.93%
Accolade
Jul 27, 2020
Initiates: Overweight
Price Target: n/a
Current: $4.19
Upside: -